Tonic regulation of middle meningeal artery diameter by ATP-sensitive potassium channels
- 20 December 2017
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 39 (4) , 670-679
Abstract
Activation of ATP-sensitive potassium (KATP) channels in arterial smooth muscle (ASM) contributes to vasodilation evoked by a variety of endogenous and exogenous compounds. Although controversial, activation of KATP channels by neuropeptides such as calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase activating peptide (PACAP) in the trigeminovascular system, including the middle meningeal artery (MMA), has been linked to migraine headache. The objective of the current study was to determine if ongoing KATP channel activity also influences MMA diameter. In the absence of other exogenous compounds, the KATP channel inhibitors glibenclamide and PNU37883A induced constriction of isolated and pressurized MMAs. In contrast, KATP channel inhibition did not alter cerebral artery diameter. Consistent with tonic KATP activity in MMA, glibenclamide also induced ASM membrane potential depolarization and increased cytosolic Ca2+. Inhibitors of cAMP-dependent protein kinase (PKA) abolished basal KATP activation in MMA and caused a marked decrease in sensitivity to the synthetic KATP channel opener, cromakalim. In vivo MMA constriction in response to gibenclamide was observed using two-photon imaging of arterial diameter. Together these results indicate that PKA-mediated tonic KATP channel activity contributes to the regulation of MMA diameter.Keywords
This publication has 50 references indexed in Scilit:
- Grand challenges in global mental healthNature, 2011
- Fundamental increase in pressure-dependent constriction of brain parenchymal arterioles from subarachnoid hemorrhage model rats due to membrane depolarizationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- The Function of Vascular Smooth Muscle Phosphodiesterase III is Preserved in Healthy Human AgingClinical and Translational Science, 2010
- Thein vivoEffect of VIP, PACAP-38 and PACAP-27 and mRNA Expression of Their Receptors in Rat Middle Meningeal ArteryCephalalgia, 2009
- Improvement of the Closed Cranial Window Model in Rats by Intracarotid Infusion of Signalling Molecules Implicated in MigraineCephalalgia, 2009
- KATP channel expression and pharmacological in vivo and in vitro studies of the KATP channel blocker PNU‐37883A in rat middle meningeal arteriesBritish Journal of Pharmacology, 2008
- Laser Speckle Flowmetry for the Study of Cerebrovascular Physiology in Normal and Ischemic Mouse CortexJournal of Cerebral Blood Flow & Metabolism, 2004
- Evidence for involvement of A‐kinase anchoring protein in activation of rat arterial KATP channels by protein kinase AThe Journal of Physiology, 2001
- Angiotensin II inhibits rat arterial KATP channels by inhibiting steady‐state protein kinase A activity and activating protein kinase CeThe Journal of Physiology, 2001
- Inhibition of vascular KATP channels by U‐37883A: a comparison with cardiac and skeletal muscleBritish Journal of Pharmacology, 1999